(R’million) | 2020 | 2019 Restatedº |
2018 |
2017 |
2016 |
Consolidated income statements | |||||
Revenue | 29 796 | 28 579 | 28 365 | 31 298 | 30 588 |
Profit before taxation, income from associates, abnormal items and impairments | 2 561 | 3 193 | 3 271 | 4 317 | 3 941 |
Income from associates | 352 | 371 | 731 | 533 | 861 |
Abnormal items and impairments | (693) | 1 762 | (620) | (583) | (324) |
Profit before taxation | 2 220 | 5 326 | 3 382 | 4 267 | 4 478 |
Taxation | (727) | (965) | (835) | (1 234) | (1 209) |
Profit for the year from continuing operations | 1 493 | 4 361 | 2 547 | 3 033 | 3 269 |
Attributable to: | |||||
Owners of the parent – continuing operations | 1 467 | 4 333 | 2 520 | 3 011 | 3 243 |
Non-controlling interests – continuing operations | 26 | 28 | 27 | 22 | 26 |
Consolidated statements of financial position | |||||
Property, plant and equipment | 5 059 | 4 976 | 4 599 | 4 588 | 4 542 |
Goodwill and intangible assets | 2 943 | 3 221 | 3 447 | 3 597 | 3 941 |
Investments | 2 855 | 2 732 | 5 102 | 4 720 | 4 905 |
Current assets | 11 035 | 11 213 | 10 764 | 10 665 | 11 099 |
Assets classified as held for sale | 419 | 24 | – | 365 | – |
Total assets | 22 311 | 22 166 | 23 912 | 23 935 | 24 487 |
Issued capital and reserves before share‑based payment reserve | 14 941 | 14 612 | 16 691 | 16 244 | 15 059 |
Share-based payment reserve | 687 | 632 | 611 | 560 | 489 |
Non-controlling interests | 159 | 163 | 163 | 257 | 487 |
Deferred taxation liability | 337 | 402 | 354 | 304 | 211 |
Provision for post-retirement medical aid | 518 | 583 | 618 | 619 | 666 |
Long-term borrowings | 197 | – | 74 | 2 | 1 069 |
Current liabilities | 5 168 | 5 625 | 5 401 | 5 776 | 6 506 |
Liabilities classified as held for sale | 304 | 149 | – | 173 | – |
Total equity and liabilities | 22 311 | 22 166 | 23 912 | 23 935 | 24 487 |
Consolidated cash flow statements | |||||
Cash operating profit after interest and taxation | 2 297 | 2 528 | 2 998 | 4 024 | 3 432 |
Working capital changes | (53) | 91 | (573) | 745 | (604) |
Dividends received | 106 | 282 | 179 | 350 | 406 |
Cash available from operations | 2 350 | 2 901 | 2 604 | 5 119 | 3 234 |
Dividends and capital distributions paid | (741) | (2 284) | (1 855) | (1 834) | (1 661) |
Net cash flow from operating activities | 1 609 | 617 | 749 | 3 285 | 1 573 |
Net cash flow from investing activities | (797) | (33) | (599) | (803) | 115 |
Net cash flow before financing activities | 812 | 584 | 150 | 2 482 | 1 688 |
Net cash flow from financing activities | (246) | (100) | (2) | (1 140) | (562) |
Net increase in cash and cash equivalents | 566 | 484 | 148 | 1 342 | 1 126 |
º | Restated as required by IFRS 5 in relation to the treatment of Value Added Meat Products (VAMP), a division of Tiger Consumer Brands Limited (Domestic operations – Consumer Brands – Food) as a discontinued operation. Refer to note 33. |